Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
24.62 EUR | -0.97% | -3.75% | -33.44% |
May. 31 | Galapagos, Adaptimmune to Jointly Develop Head, Neck Cancer Treatment | MT |
May. 31 | Galapagos, Adaptimmune Therapeutics Team Up to Evaluate Head and Neck Cancer Drug | MT |
- Stock Market
- Equities
- GLPG Stock
- News Galapagos NV
- MarketScreener Strategies